search
Back to results

Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis

Primary Purpose

Bacterial Vaginosis

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
probiotic yoghurt
chemically acidified milk
Arilin
Sponsored by
Clinical Research Center Kiel GmbH
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Bacterial Vaginosis focused on measuring bacterial vaginosis, probiotics, Amsel Score, Nugent Score

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

To be enrolled, the following criteria have to be fulfilled:

  1. Woman aged ≥ 18 years with stable menstrual cycle or postmenopausal women
  2. Newly diagnosed bacterial vaginosis based on Amsel criteria
  3. Complies with a standard oral antibiotic treatment with Metronidazol for 7 days, 2 x 500mg/day)
  4. Willing to consume for 4 weeks the study product two times daily
  5. Willingness to abstain from food and supplements containing probiotics, prebiotics and other fermented products as well as dietary supplements
  6. Not in menses at the time of the first examination at the gynaecologist (G1)
  7. Written informed consent

Exclusion Criteria:

  1. Subjects currently enrolled in another clinical study.
  2. Subjects having finished another clinical study within the last 4 weeks before inclusion.
  3. Infection caused by Chlamydia trachomatis
  4. Infection caused by Neisseria gonorrhoea
  5. Infection caused by Trichomonas vaginalis
  6. Infection caused by Candida albicans or other mycosis
  7. Leucocytes present in the vaginal smear
  8. PAP-testing ≥ 3 (anamnestically)
  9. Vulvovaginal inflammation as macroscopically identified by the gynaecologist
  10. Dyspareunia
  11. Pregnancy and breastfeeding
  12. Chemically based contraceptives (e.g. suppositories, salves, foam, gel)
  13. Irregular cycles (e.g. polymenorrhoea, metrorrhagia)
  14. Dysuria
  15. Infection of the urinary tract
  16. Chronic or sporadic abdominal pain with exception of dysmenorrhoea
  17. Any ano-rectal infection, disease, surgery in the medical history or current
  18. Anus praeter
  19. Hypersensitivity, allergy or idiosyncratic reaction to metronidazole or any similar active substances.
  20. Hypersensitivity, allergy or idiosyncratic reaction to any component of the yoghurt (e.g. lactose intolerance, allergy against milk protein)
  21. Any disease or condition which might compromise significantly the hematopoietic, renal, endocrine, pulmonary, hepatic, gastrointestinal, cardiovascular, immunological, central nervous, dermatological or any other body system with the exception of the conditions defined by the inclusion criteria.
  22. History of hepatitis B and C
  23. History of HIV infection
  24. Regular medical treatment including OTC, which may have impact on the study aims (e.g. probiotics, antibiotic drugs, laxatives etc.)
  25. Major cognitive or psychiatric disorders
  26. Subjects who are scheduled to undergo hospitalization during the study period
  27. Eating disorders (e.g. anorexia, bulimia) or special diets (e.g. vegan, vegetarian)
  28. Present drug abuse or alcoholism, reformed alcoholic
  29. Legal incapacity

Sites / Locations

  • CRC Clinical Research Center Kiel

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

probiotic yoghurt & Arilin

chemically acidified milk & Arilin

Arm Description

probiotic yoghurt, 2 units (125 g), containing living strains of L.crispatus, L.gasseri, L.rhamnosus, L.jensenii, each in a concentration of 1 x 107 CFU/ml product for 4 weeks Two yoghurts are consumed every day for 28 days. 2 tablets Metronidazol 500mg daily for 7 days

chemically (H3PO4) acidified milk (125g) without bacterial strains. Two products are consumed every day for 28 days. 2 tablets Metronidazol 500mg daily for 7 days

Outcomes

Primary Outcome Measures

Rate of BV-free woman
The rate of BV-free women at the end of the yoghurt consumption period (day 28) as assessed by Nugent score

Secondary Outcome Measures

Alteration (G2 - G1) of Nugent Score
Alteration (G2 - G1) of symptom score based on Amsel criteria (Yes=1; No=0) and 3 (Yes=1; No=0) resulting in a score ranging from 0 to 2

Full Information

First Posted
March 31, 2016
Last Updated
November 16, 2016
Sponsor
Clinical Research Center Kiel GmbH
Collaborators
Dairyfem R&D GmbH, University of Natural Resources and Life Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT02744638
Brief Title
Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis
Official Title
Double-blind, Randomized, Controlled Trial to Evaluate the Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains (L. Crispatus, L. Gasseri, L. Rhamnosus, L. Jensenii) on Bacterial Vaginosis (BV) in Adult Women
Study Type
Interventional

2. Study Status

Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
February 2015 (undefined)
Primary Completion Date
August 2016 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clinical Research Center Kiel GmbH
Collaborators
Dairyfem R&D GmbH, University of Natural Resources and Life Sciences

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is, to investigate, whether the consumption of a probiotic yoghurt containing 4 probiotic strains naturally colonizing the vagina (L. crispatus, L. gasseri, L. rhamnosus, L. jensenii) has an influence on the comfort of adult women with BV after and 3 weeks following a standard antibiotic treatment with metronidazole.
Detailed Description
Female volunteers aged ≥18 years with stable menstrual cycle or postmenopausal women presenting with a newly diagnosed bacterial vaginosis based on Amsel criteria, complying with a standard oral antibiotic treatment (Metronidazol (Arilin®) 7 days 2x500mg), willing to consume for 4 weeks the study product two times daily, complying with the dietary restrictions (s. a.) and complying with the other inclusion and exclusion criteria will be enrolled in the study. After enrollment subjects will be randomly and evenly assigned to one of the two test groups verum and placebo.The study population will be recruited in a screening examination (G1) by gynaecologists from Kiel area. This screening examination (routine examination) by gynaecologist is used to provide the diagnosis BV. After enrolment subjects will be randomly assigned to one of the two test groups verum (n=108) and placebo (n=108).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bacterial Vaginosis
Keywords
bacterial vaginosis, probiotics, Amsel Score, Nugent Score

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
probiotic yoghurt & Arilin
Arm Type
Experimental
Arm Description
probiotic yoghurt, 2 units (125 g), containing living strains of L.crispatus, L.gasseri, L.rhamnosus, L.jensenii, each in a concentration of 1 x 107 CFU/ml product for 4 weeks Two yoghurts are consumed every day for 28 days. 2 tablets Metronidazol 500mg daily for 7 days
Arm Title
chemically acidified milk & Arilin
Arm Type
Placebo Comparator
Arm Description
chemically (H3PO4) acidified milk (125g) without bacterial strains. Two products are consumed every day for 28 days. 2 tablets Metronidazol 500mg daily for 7 days
Intervention Type
Other
Intervention Name(s)
probiotic yoghurt
Other Intervention Name(s)
verum
Intervention Description
verum is a liquid probiotic yoghurt containing all four probiotics as described in the arm description. Study participants consume daily two bottles (125g) during an intervention period of four weeks.
Intervention Type
Other
Intervention Name(s)
chemically acidified milk
Other Intervention Name(s)
placebo
Intervention Description
Placebo is chemically acidified milk without bacterial strains. Study participants consume daily two bottles (125g) during an intervention period of four weeks (randomly assigned).
Intervention Type
Drug
Intervention Name(s)
Arilin
Other Intervention Name(s)
Metronidazol
Intervention Description
2 tablets Arilin 500mg for 7 days
Primary Outcome Measure Information:
Title
Rate of BV-free woman
Description
The rate of BV-free women at the end of the yoghurt consumption period (day 28) as assessed by Nugent score
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Alteration (G2 - G1) of Nugent Score
Time Frame
4 weeks
Title
Alteration (G2 - G1) of symptom score based on Amsel criteria (Yes=1; No=0) and 3 (Yes=1; No=0) resulting in a score ranging from 0 to 2
Time Frame
4 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: To be enrolled, the following criteria have to be fulfilled: Woman aged ≥ 18 years with stable menstrual cycle or postmenopausal women Newly diagnosed bacterial vaginosis based on Amsel criteria Complies with a standard oral antibiotic treatment with Metronidazol for 7 days, 2 x 500mg/day) Willing to consume for 4 weeks the study product two times daily Willingness to abstain from food and supplements containing probiotics, prebiotics and other fermented products as well as dietary supplements Not in menses at the time of the first examination at the gynaecologist (G1) Written informed consent Exclusion Criteria: Subjects currently enrolled in another clinical study. Subjects having finished another clinical study within the last 4 weeks before inclusion. Infection caused by Chlamydia trachomatis Infection caused by Neisseria gonorrhoea Infection caused by Trichomonas vaginalis Infection caused by Candida albicans or other mycosis Leucocytes present in the vaginal smear PAP-testing ≥ 3 (anamnestically) Vulvovaginal inflammation as macroscopically identified by the gynaecologist Dyspareunia Pregnancy and breastfeeding Chemically based contraceptives (e.g. suppositories, salves, foam, gel) Irregular cycles (e.g. polymenorrhoea, metrorrhagia) Dysuria Infection of the urinary tract Chronic or sporadic abdominal pain with exception of dysmenorrhoea Any ano-rectal infection, disease, surgery in the medical history or current Anus praeter Hypersensitivity, allergy or idiosyncratic reaction to metronidazole or any similar active substances. Hypersensitivity, allergy or idiosyncratic reaction to any component of the yoghurt (e.g. lactose intolerance, allergy against milk protein) Any disease or condition which might compromise significantly the hematopoietic, renal, endocrine, pulmonary, hepatic, gastrointestinal, cardiovascular, immunological, central nervous, dermatological or any other body system with the exception of the conditions defined by the inclusion criteria. History of hepatitis B and C History of HIV infection Regular medical treatment including OTC, which may have impact on the study aims (e.g. probiotics, antibiotic drugs, laxatives etc.) Major cognitive or psychiatric disorders Subjects who are scheduled to undergo hospitalization during the study period Eating disorders (e.g. anorexia, bulimia) or special diets (e.g. vegan, vegetarian) Present drug abuse or alcoholism, reformed alcoholic Legal incapacity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christiane Laue, Dr. med.
Organizational Affiliation
CRC Clinical Research Center Kiel
Official's Role
Principal Investigator
Facility Information:
Facility Name
CRC Clinical Research Center Kiel
City
Kiel
State/Province
Schleswig-Holstein
ZIP/Postal Code
24118
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis

We'll reach out to this number within 24 hrs